Revat Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.50 Cr
- Paid Up Capital ₹ 5.33 Cr
- Company Age 36 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 66.90 Cr
- Satisfied Charges ₹ 57.85 Cr
- Revenue Growth 35.90%
- Profit Growth 104.74%
- Ebitda 44.62%
- Net Worth 32.45%
- Total Assets 34.14%
About Revat Laboratories
Revat Laboratories Private Limited (RLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 07 June 1988 and has a history of 36 years and eight months. Its registered office is in Rangareddy, Telangana, India.
The Corporate was formerly known as Minopharm Laboratories Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 5.50 Cr and a paid-up capital of Rs 5.33 Cr.
The company currently has active open charges totaling ₹66.90 Cr. The company has closed loans amounting to ₹57.85 Cr, as per Ministry of Corporate Affairs (MCA) records.
Aruna Karusala, Anil Karusala, and Vijitha Gorrepati serve as directors at the Company.
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230TG1988PTC008741
- Company No.
008741
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jun 1988
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Revat Laboratories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aruna Karusala  | Director | 07-Jun-1988 | Current |
| Anil Karusala | Director | 15-Mar-1994 | Current |
| Vijitha Gorrepati | Director | 28-Mar-2011 | Current |
Financial Performance of Revat Laboratories.
Revat Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 35.9% increase. The company also saw a substantial improvement in profitability, with a 104.74% increase in profit. The company's net worth Soared by an impressive increase of 32.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Revat Laboratories?
In 2022, Revat Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sai Parenteral's LimitedAruna Karusala, Anil Karusala and 1 more are mutual person
Phyto Chem (India) LimitedVijitha Gorrepati is a mutual person
Rohini Solares Private LimitedAnil Karusala is a mutual person
- Aanandi Hotels & Resorts Private Limited
Anil Karusala is a mutual person
- Sp Analytics Private Limited
Anil Karusala and Vijitha Gorrepati are mutual person
Charges (Loans)
₹66.90 Cr
₹57.85 Cr
Charges Breakdown by Lending Institutions
- City Union Bank Limited : 34.71 Cr
- Others : 26.90 Cr
- The Hongkong And Shanghai Banking Corporation Limited : 5.00 Cr
- State Bank Of India : 0.20 Cr
- Andhra Bank : 0.09 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Feb 2022 | The Hongkong And Shanghai Banking Corporation Limited | ₹5.00 Cr | Open |
| 21 Oct 2021 | City Union Bank Limited | ₹2.50 Cr | Open |
| 12 Jul 2021 | City Union Bank Limited | ₹2.00 Cr | Open |
| 18 May 2019 | City Union Bank Limited | ₹5.00 M | Open |
| 10 May 2019 | City Union Bank Limited | ₹29.71 Cr | Open |
How Many Employees Work at Revat Laboratories?
Revat Laboratories has a workforce of 6 employees as of May 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Revat Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Revat Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
